249 related articles for article (PubMed ID: 31527255)
1. Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target.
Li Y; Xu Y; Benitez BA; Nagree MS; Dearborn JT; Jiang X; Guzman MA; Woloszynek JC; Giaramita A; Yip BK; Elsbernd J; Babcock MC; Lo M; Fowler SC; Wozniak DF; Vogler CA; Medin JA; Crawford BE; Sands MS
Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20097-20103. PubMed ID: 31527255
[TBL] [Abstract][Full Text] [Related]
2. Genetic ablation of Saposin-D in Krabbe disease eliminates psychosine accumulation but does not significantly improve demyelination.
Watanabe T; Tsuboi K; Matsuda N; Ishizuka Y; Go S; Watanabe E; Ono A; Okamoto Y; Matsuda J
J Neurochem; 2023 Aug; 166(4):720-746. PubMed ID: 37337846
[TBL] [Abstract][Full Text] [Related]
3. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
[TBL] [Abstract][Full Text] [Related]
4. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
5. β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and
Coltrini D; Chandran AMK; Belleri M; Poliani PL; Cominelli M; Pagani F; Capra M; Calza S; Prioni S; Mauri L; Prinetti A; Kofler JK; Escolar ML; Presta M
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012705
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
7. Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease.
Iacono D; Koga S; Peng H; Manavalan A; Daiker J; Castanedes-Casey M; Martin NB; Herdt AR; Gelb MH; Dickson DW; Lee CW
Neurobiol Dis; 2022 Nov; 174():105862. PubMed ID: 36113749
[TBL] [Abstract][Full Text] [Related]
8. Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease.
Potter GB; Santos M; Davisson MT; Rowitch DH; Marks DL; Bongarzone ER; Petryniak MA
Hum Mol Genet; 2013 Sep; 22(17):3397-414. PubMed ID: 23620143
[TBL] [Abstract][Full Text] [Related]
9. Krabbe disease: involvement of connexin43 in the apoptotic effects of sphingolipid psychosine on mouse oligodendrocyte precursors.
Graziano AC; Parenti R; Avola R; Cardile V
Apoptosis; 2016 Jan; 21(1):25-35. PubMed ID: 26459425
[TBL] [Abstract][Full Text] [Related]
10. Insights into the Pathogenesis and Treatment of Krabbe Disease.
Bongarzone ER; Escolar ML; Gray SJ; Kafri T; Vite CH; Sands MS
Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():689-96. PubMed ID: 27491217
[TBL] [Abstract][Full Text] [Related]
11. Effect of vitamin D3 intake on the onset of disease in a murine model of human Krabbe disease.
Paintlia MK; Singh I; Singh AK
J Neurosci Res; 2015 Jan; 93(1):28-42. PubMed ID: 25236689
[TBL] [Abstract][Full Text] [Related]
12. Role of endogenous psychosine accumulation in oligodendrocyte differentiation and survival: implication for Krabbe disease.
Won JS; Kim J; Paintlia MK; Singh I; Singh AK
Brain Res; 2013 May; 1508():44-52. PubMed ID: 23438514
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of spontaneously immortalized Schwann cells from murine model of globoid cell leukodystrophy (twitcher).
Shen JS; Watabe K; Meng XL; Ida H; Ohashi T; Eto Y
J Neurosci Res; 2002 Jun; 68(5):588-94. PubMed ID: 12111848
[TBL] [Abstract][Full Text] [Related]
14. Reduction in miR-219 expression underlies cellular pathogenesis of oligodendrocytes in a mouse model of Krabbe disease.
Inamura N; Go S; Watanabe T; Takase H; Takakura N; Nakayama A; Takebayashi H; Matsuda J; Enokido Y
Brain Pathol; 2021 Sep; 31(5):e12951. PubMed ID: 33822434
[TBL] [Abstract][Full Text] [Related]
15. A novel brain-penetrant oral UGT8 inhibitor decreases in vivo galactosphingolipid biosynthesis in murine Krabbe disease.
Zaccariotto E; Cachón-González MB; Wang B; Lim S; Hirth B; Park H; Fezoui M; Sardi SP; Mason P; Barker RH; Cox TM
Biomed Pharmacother; 2022 May; 149():112808. PubMed ID: 35290889
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
[TBL] [Abstract][Full Text] [Related]
17. Murine, canine and non-human primate models of Krabbe disease.
Wenger DA
Mol Med Today; 2000 Nov; 6(11):449-51. PubMed ID: 11074371
[TBL] [Abstract][Full Text] [Related]
18. Progressive accumulation of toxic metabolite in a genetic leukodystrophy.
Igisu H; Suzuki K
Science; 1984 May; 224(4650):753-5. PubMed ID: 6719111
[TBL] [Abstract][Full Text] [Related]
19. Developmental defects and aberrant accumulation of endogenous psychosine in oligodendrocytes in a murine model of Krabbe disease.
Inamura N; Kito M; Go S; Kishi S; Hosokawa M; Asai K; Takakura N; Takebayashi H; Matsuda J; Enokido Y
Neurobiol Dis; 2018 Dec; 120():51-62. PubMed ID: 30176352
[TBL] [Abstract][Full Text] [Related]
20. Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes.
Mangiameli E; Cecchele A; Morena F; Sanvito F; Matafora V; Cattaneo A; Della Volpe L; Gnani D; Paulis M; Susani L; Martino S; Di Micco R; Bachi A; Gritti A
Stem Cell Reports; 2021 Jun; 16(6):1478-1495. PubMed ID: 33989519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
